AssetMark’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
Other funds holding BLFS
AssetMark's BLFS Position: Q3 2026 in Review
AssetMark reduced its BioLife Solutions (BLFS) stake by 68% in Q3 2026, selling an estimated $642 and leaving 9 shares worth $350. The position accounts for ﹤0.01% of the portfolio, ranked #3504.
AssetMark first reported a position in BLFS in Q4 2025 and has held it in 4 quarters since. The position peaked at $791 in Q2 2026. 176 funds tracked by Wall St. Rank hold BLFS as of Q3 2026.
- AssetMark held 9 shares of BioLife Solutions worth $350 as of Q3 2026.
- AssetMark sold 19 BioLife Solutions shares in Q3 2026, an estimated $642.
- BioLife Solutions made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3504 holding.
- AssetMark first reported a position in BioLife Solutions in Q4 2025 and has held it in 4 quarters since.
- AssetMark's BioLife Solutions position peaked at $791 in Q2 2026.
- 176 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.